Literature DB >> 22443121

Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects.

Masashi Osugi1, Wataru Katagiri, Ryoko Yoshimi, Takeharu Inukai, Hideharu Hibi, Minoru Ueda.   

Abstract

Tissue engineering has recently become available as a treatment procedure for bone augmentation. However, this procedure has several problems, such as high capital investment and expensive cell culture, complicated safety and quality management issues regarding cell handling, and patient problems with the invasive procedure of cell collection. Moreover, it was reported that stem cells secrete many growth factors and chemokines during their cultivation, which could affect cellular characteristics and behavior. This study investigated the effect of stem-cell-cultured conditioned media on bone regeneration. Cultured conditioned media from human bone marrow-derived mesenchymal stem cells (MSC-CM) enhanced the migration, proliferation, and expression of osteogenic marker genes, such as osteocalcin and Runx2, of rat MSCs (rMSCs) in vitro. MSC-CM includes cytokines such as insulin-like growth factor-1 and vascular endothelial growth factor. In vivo, a prepared bone defect of a rat calvarial model was implanted in five different rat groups using one of the following graft materials: human MSCs/agarose (MSCs), MSC-CM/agarose (MSC-CM), Dulbecco's modified Eagle's medium without serum [DMEM(-)]/agarose [DMEM(-)], PBS/agarose (PBS), and defect only (Defect). After 4 and 8 weeks, implant sections were evaluated using microcomputed tomography (micro-CT) and histological analysis. Micro-CT analysis indicated that the MSC-CM group had a greater area of newly regenerated bone compared with the other groups (p<0.05) and histological analysis at 8 weeks indicated that the newly regenerated bone bridge almost covered the defect. Interestingly, the effects of MSC-CM were stronger than those of the MSC group. In vivo imaging and immunohistochemical staining of transgenic rats expressing green fluorescent protein also showed that migration of rMSCs to the bone defect in the MSC-CM group was greater than in the other groups. These results demonstrated that MSC-CM can regenerate bone through mobilization of endogenous stem cells. The use of stem-cell-cultured conditioned media for bone regeneration is a unique concept that utilizes paracrine factors of stem cells without cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22443121      PMCID: PMC3397118          DOI: 10.1089/ten.TEA.2011.0325

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  46 in total

1.  Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors:  Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

2.  Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.

Authors:  K Le Blanc; L Tammik; B Sundberg; S E Haynesworth; O Ringdén
Journal:  Scand J Immunol       Date:  2003-01       Impact factor: 3.487

3.  Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration.

Authors:  Yoichi Yamada; Minoru Ueda; Takahito Naiki; Makoto Takahashi; Ken-Ichiro Hata; Tetsuro Nagasaka
Journal:  Tissue Eng       Date:  2004 May-Jun

4.  Harvesting autogenous iliac bone grafts. A review of complications and techniques.

Authors:  L T Kurz; S R Garfin; R E Booth
Journal:  Spine (Phila Pa 1976)       Date:  1989-12       Impact factor: 3.468

5.  In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats.

Authors:  E M Spencer; C C Liu; E C Si; G A Howard
Journal:  Bone       Date:  1991       Impact factor: 4.398

6.  Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells.

Authors:  S Wislet-Gendebien; P Leprince; G Moonen; B Rogister
Journal:  J Cell Sci       Date:  2003-07-02       Impact factor: 5.285

Review 7.  Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants.

Authors:  Tadafumi Kawamoto
Journal:  Arch Histol Cytol       Date:  2003-05

Review 8.  Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician?

Authors:  Nikitas Sykaras; Lynne A Opperman
Journal:  J Oral Sci       Date:  2003-06       Impact factor: 1.556

9.  Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation.

Authors:  B Maitra; E Szekely; K Gjini; M J Laughlin; J Dennis; S E Haynesworth; O N Koç
Journal:  Bone Marrow Transplant       Date:  2004-03       Impact factor: 5.483

10.  Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; M Shou; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

View more
  113 in total

1.  Co-culture with periodontal ligament stem cells enhanced osteoblastic differentiation of MC3T3-E1 cells and osteoclastic differentiation of RAW264.7 cells.

Authors:  Shulan Chen; Xin Ye; Xinbo Yu; Quanchen Xu; Keqing Pan; Shulai Lu; Pishan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Osteogenic differentiation and gene expression profile of human dental follicle cells induced by human dental pulp cells.

Authors:  Su-Jin Park; Hyun-Sook Bae; Joo-Cheol Park
Journal:  J Mol Histol       Date:  2014-12-18       Impact factor: 2.611

Review 3.  In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability.

Authors:  Fatemeh Amiri; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2014-12-20       Impact factor: 3.667

Review 4.  Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potential.

Authors:  Caterina Pipino; Assunta Pandolfi
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

5.  A defined mix of cytokines mimics conditioned medium from cultures of bone marrow-derived mesenchymal stem cells and elicits bone regeneration.

Authors:  Wataru Katagiri; Kohei Sakaguchi; Takamasa Kawai; Yukiko Wakayama; Masashi Osugi; Hideharu Hibi
Journal:  Cell Prolif       Date:  2017-01-30       Impact factor: 6.831

6.  Reconstructing jaw defects with MSCs and PLGA-encapsulated growth factors.

Authors:  Boon Ching Tee; Kashappa Goud H Desai; Kelly S Kennedy; Brittany Sonnichsen; Do-Gyoon Kim; Henry W Fields; Susan R Mallery; Steven P Schwendeman; Zongyang Sun
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

7.  Conditioning of myoblast secretome using mesenchymal stem/stromal cell spheroids improves bone repair.

Authors:  Augustine M Saiz; Marissa A Gionet-Gonzales; Mark A Lee; J Kent Leach
Journal:  Bone       Date:  2019-05-16       Impact factor: 4.398

8.  Secretomes from mesenchymal stem cells participate in the regulation of osteoclastogenesis in vitro.

Authors:  Kenichi Ogata; Wataru Katagiri; Hideharu Hibi
Journal:  Clin Oral Investig       Date:  2016-10-29       Impact factor: 3.573

9.  Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration.

Authors:  Meadhbh Á Brennan; Pierre Layrolle; David J Mooney
Journal:  Adv Funct Mater       Date:  2020-03-11       Impact factor: 18.808

10.  Peripheral Nerve Regeneration by Secretomes of Stem Cells from Human Exfoliated Deciduous Teeth.

Authors:  Yukiko Sugimura-Wakayama; Wataru Katagiri; Masashi Osugi; Takamasa Kawai; Kenichi Ogata; Kohei Sakaguchi; Hideharu Hibi
Journal:  Stem Cells Dev       Date:  2015-08-10       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.